The diagnostic and prognostic potential of the EGFR/MUC4/MMP9 axis in glioma patients

Glioblastoma is the most aggressive form of brain cancer, presenting poor prognosis despite current advances in treatment. There is therefore an urgent need for novel biomarkers and therapeutic targets. Interactions between mucin 4 (MUC4) and the epidermal growth factor receptor (EGFR) are involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Quesnel, Agathe, Coles, Nathan, Polvikoski, Tuomo M., Karagiannis, George S., Angione, Claudio, Islam, Meez, Khundakar, Ahmad A., Filippou, Panagiota S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674618/
https://www.ncbi.nlm.nih.gov/pubmed/36400876
http://dx.doi.org/10.1038/s41598-022-24099-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674618/
https://www.ncbi.nlm.nih.gov/pubmed/36400876
http://dx.doi.org/10.1038/s41598-022-24099-4

Ejemplares similares